On the other hand, this correlation is lost in the case of the basal-like subtype, so that in the breast cancer luminal subtypes, we can deduce that both TFEB and CARM1 act in the same pathway, while this may not be true in the case of the basal-like molecular subtype [15]. This evidence concerns the gene CARM1 and breast cancer.